PROJECT TEAMS
Current Projects
CereCe
Project CereCe aims to empower self-directed mobility for tetraplegic individuals by leveraging gaze-tracking and brain-computer interface (BCI) technology. The team is currently developing a retrofittable wheelchair that integrates electroencephalography (EEG) and a mounted camera to interpret users' neurological signals and guide the wheelchair's movement.
​
Comprising students and graduates from diverse fields—including medicine, engineering, computer science, data science, arts, law, and commerce—Project CereCe brings a multidisciplinary approach to innovation. The team is actively engaging with conferences, researchers and accelerators to advance their groundbreaking work.
docuMed
Project docuMed is developing a web-based application that leverages natural language processing (NLP) and other machine-learning tools to generate automated patient reports derived from outpatient consultations. This workflow will enhance patient recall, promote informed consent, and streamline the healthcare experience for patients.
​
Project docuMed originated from the 2022 Vinuri de Silva Biodesign Competition. It is a multidisciplinary team of medical students, NLP researchers, and Human-Computer Interaction designers, united in their commitment to delivering innovative and impactful solutions in healthcare.
Sensure
Project Sensure began as a volunteer-driven initiative born out of the BioDesign Innovation program, and has since evolved into a company focused on commercialising a medtech device for lumbar puncture training. While the company advances product development and market entry, the student-volunteer team drives long-term project growth, innovation, and hands-on learning. Together, we are developing a training tool that enhances procedural skill acquisition through real-time sensory feedback. In 2025, we aim to launch our first product, bringing impactful technology to clinical education. We look forward to building and growing with the medtech innovation community.
Volo
Volo is an innovative project focused on developing a lightweight, wearable device for active compression therapy to treat lymphoedema, a condition characterised by excessive fluid accumulation in soft tissues, often resulting from cancer treatment or genetic factors. Founded in 2022 through MBSI's Vinuri De Silva Biodesign competition as Project Mobi, Volo was awarded the Graeme Clark Institute Prize for its promising approach to addressing lymphoedema. Since then, the team has built a strong community of patients and clinicians who provide critical insights into the real-world challenges faced by individuals living with lymphoedema. This collaboration ensures that Volo’s design is grounded in the needs of its end-users.
​
In 2024, Volo further advanced its development by joining the Monash Generator Accelerator and MedTech Actuator Origins programs, where the team enhanced its business acumen and planning capabilities. These experiences have enabled Volo to refine its strategy for commercialization and clinical implementation. Looking ahead, in 2025, the team aims to finalise a working prototype of its therapy device and make preparations for a clinical trial, marking a significant step toward delivering an effective, patient-friendly solution for lymphoedema management.
Chyral
Chyral is developing an optical sensing platform for reagent-free, multi-biomarker blood analysis. The initial focus is on a continuous monitoring system for ICU patients, integrating with existing arterial lines in ICUs. This innovative technology addresses the critical need for real-time monitoring of important physiological parameters, enabling earlier diagnosis, interventions, and treatments for life-threatening conditions like sepsis and shock.
​
Recent achievements include but are not limited to completing MAP Velocity (2024), raising angel investment for proof-of-concept study, winning first place at Blackbird Foundry (2024), and being selected to present at the Started@Melbourne Showcase 2024. In 2025, Chyral will complete the MTAC Accelerator and continue to refine the prototype.
Endometronics
Project Endometronics is exploring solutions that will improve the accuracy and efficiency of current diagnosis methods for Endometriosis, with a focus on improving the surgical outcomes of endoscopic surgeries.
​
Project Endometronics originated from the 2023 Vinuri De Silva Biodesign Competition. After achieving the Vinuri De Silva Biodesign Competition Prize, the team proceeded to the semi-finals in the 2023 Medtech Actuator Origin Program. The team consists of biomedical engineering, biotech and science students all collaborating to build and validate a proof of concept by the end of 2025.
Celiva
Project Celiva is developing a saliva-based rapid antigen test to screen for celiac disease (CeD) and gluten insensitivity based on anti-gluten and oral microbiome anti-bacterial antibodies. Our test can exponentially reduce pain, cost and time associated with both CeD diagnosis and treatment. Celiva originated in the Summer25 Cohort of the Startmate Student Fellowship, where a 2nd place pitch gave us a free position in their Launch Club pre-accelerator. Our goals by the end of the year are to conduct a pilot study analyzing saliva swabs the pediatric CeD population and to design a physical MVP for our test using Co-Lab space based on study results.​
Assistive Contact Lens Device (ACLD)
Project ACLD aims to conduct a comprehensive preliminary evaluation of a potential assistive device designed to simplify the process of wearing contact lenses. By exploring the business, technical, and optometry aspects, as well as building a functional prototype, we seek to determine the feasibility and viability of developing this product. The project will span one year and culminate in detailed reports on market research, technical feasibility, optometric insights, and prototype performance, ultimately informing the decision on whether to proceed with full-scale product development.​
